Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 1
1987 2
1988 2
1989 2
1990 4
1991 1
1992 3
1993 2
1994 1
1995 6
1996 8
1997 2
1998 6
1999 2
2000 3
2001 5
2002 2
2003 9
2004 8
2005 6
2006 11
2007 25
2008 24
2009 19
2010 40
2011 27
2012 26
2013 24
2014 54
2015 53
2016 75
2017 93
2018 106
2019 152
2020 176
2021 199
2022 183
2023 189
2024 80

Text availability

Article attribute

Article type

Publication date

Search Results

1,430 results

Results by year

Filters applied: . Clear all
Page 1
The role of tetraspanins pan-cancer.
Huang R, Sun H, Lin R, Zhang J, Yin H, Xian S, Li M, Wang S, Li Z, Qiao Y, Jiang M, Yan P, Meng T, Huang Z. Huang R, et al. Among authors: meng t. iScience. 2022 Jul 19;25(8):104777. doi: 10.1016/j.isci.2022.104777. eCollection 2022 Aug 19. iScience. 2022. PMID: 35992081 Free PMC article.
Prohibitin 1 regulates mtDNA release and downstream inflammatory responses.
Liu H, Fan H, He P, Zhuang H, Liu X, Chen M, Zhong W, Zhang Y, Zhen C, Li Y, Jiang H, Meng T, Xu Y, Zhao G, Feng D. Liu H, et al. Among authors: meng t. EMBO J. 2022 Dec 15;41(24):e111173. doi: 10.15252/embj.2022111173. Epub 2022 Oct 17. EMBO J. 2022. PMID: 36245295 Free PMC article.
Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E-based Antibody-Drug Conjugate for Treatment of Nectin-4-expressing Cancers.
Zhou W, Fang P, Yu D, Ren H, You M, Yin L, Mei F, Zhu H, Wang Z, Xu H, Cao Y, Sun X, Xu X, Bi J, Wang J, Ma L, Wang X, Chen L, Zhang Y, Cen X, Zhu X, Lou L, Liu D, Tan X, Yang J, Meng T, Shen J. Zhou W, et al. Among authors: meng t. Mol Cancer Ther. 2023 Aug 1;22(8):913-925. doi: 10.1158/1535-7163.MCT-22-0743. Mol Cancer Ther. 2023. PMID: 37196158 Free PMC article.
1,430 results